Spitzoid and non-spitzoid melanoma in children. A prognostic comparative study

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 10, 2013, Pages 1214-1221

  Paradela, S ^a   Fonseca, E ^a   Pita Fernandez S ^a   Prieto, V G ^b  

^a Oral and Maxillofacial Surgery Service University Hospital of La Coruña   (Spain)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; AGE; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER REGRESSION; CANCER SURVIVAL; CAUCASIAN; CHILD; CHILDHOOD CANCER; COMPARATIVE STUDY; CONGENITAL NEVUS; CONTROLLED STUDY; CUTANEOUS MELANOMA; DISTANT METASTASIS; DYSPLASTIC NEVUS; ETHNIC GROUP; FAMILIAL CANCER; FEMALE; GENDER; GROWTH CURVE; HISPANIC; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; JUVENILE MELANOMA; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MELANOCYTIC NEVUS; MELANOMA; METASTASIS POTENTIAL; MINIMAL RESIDUAL DISEASE; MITOSIS RATE; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SAMPLING; SAMPLING ERROR; SENTINEL LYMPH NODE BIOPSY; SKIN ATROPHY; SKIN ULCER; SPITZOID MELANOMA; THICKNESS; TUMOR INVASION;

ADOLESCENT; AGE FACTORS; BIOPSY; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MELANOMA; NEOPLASM STAGING; NEVUS, EPITHELIOID AND SPINDLE CELL; PROGNOSIS; RETROSPECTIVE STUDIES; SKIN; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 84884905941     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2012.04686.x     Document Type: Article

References (40)

1. Wechsler J, Bastuji-Garin S, Spatz A, et al. Reliability of the histopathologic diagnosis of malignant melanoma in childhood. Arch Dermatol 2002; 138: 625-628.
2. Paradela S, Fonseca E, Pita-Fernández S, et al. Prognostic factors for melanoma in children and adolescents: a clinicopathologic, single-center study of 137 patients. Cancer 2010; 116: 4334-4344.
3. Paradela S, Fonseca E, Pita S, et al. Spitzoid melanoma in children: clinico-pathologic study and application of immunohistochemistry as an adjunct diagnostic tool. J Cutan Pathol 2009; 36: 740-752.
4. Paradela S, Fonseca E, Pita-Fernandez S, et al. Melanoma under 18 years and pregnancy: report of three cases. Eur J Dermatol 2010; 20: 186-188.
5. Prieto VG, Clark SH,. Processing of sentinel lymph nodes for detection of metastatic melanoma. Ann Diagn Pathol 2002; 6: 257-264.
6. Gershenwald JE, Andtbacka RH, Prieto VG, et al. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol 2008; 26: 4296-4303.
7. Prieto VG,. Sentinel Lymph nodes in cutaneous melanoma. Surg Pathol Clin 2009; 2: 553-563.
8. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American joint committee on cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19: 3635-3648.
9. Barnhill RL, Gupta K,. Unusual variants of malignant melanoma. Clin Dermatol 2009; 27: 564-587.
10. van Dijk MC, Bernsen MR, Ruiter DJ,. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma. Am J Surg Pathol 2005; 29: 1145-1151.
11. Bastian BC, LeBoit PE, Pinkel D,. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol 2000; 157: 967-972.
12. Gill M, Cohen J, Renwick N, et al. Genetic similarities between Spitz nevus and spitzoid melanoma in children. Cancer 2004; 101: 2636-2640.
13. Fullen DR, Poynter JN, Lowe L, et al. BRAF and NRAS mutations in spitzoid melanocytic lesions. Mod Pathol 2006; 19: 1324-1332.
14. Mihic-Probst D, Perren A, Schmid S, et al. Absence of BRAF gene mutations differentiates Spitz nevi from malignant melanoma. Anticancer Res 2004; 24: 2415-2418.
15. Lee DA, Cohen JA, Twaddell WS, et al. Are all melanomas the same? Spitzoid melanoma is a distinct subtype of melanoma. Cancer 2006; 106: 907-913.
16. Takata M, Lin J, Takayanagi S, et al. Genetic and epigenetic alterations in the differential diagnosis of malignant melanoma and spitzoid lesion. Br J Dermatol 2007; 156: 1287-1294.
17. Garrido-Ruiz MC, Requena L, Ortiz P, et al. The immunohistochemical profile of Spitz nevi and conventional (non-spitzoid) melanomas: a baseline study. Mod Pathol 2010; 23: 1215-1224.
18. Paradela S, Fonseca E, Prieto VG,. Melanoma in children. Arch Path Lab Med 2011; 135: 307-316.
19. Pol-Rodriquez M, Lee S, Silvers DN, Celebi JT,. Influence of age on survival in childhood spitzoid melanomas. Cancer 2007; 109: 1579-1583.
20. Tate PS, Ronan SG, Feucht KA, et al. Melanoma in childhood and adolescence: clinical and pathological features of 48 cases. J Pediatr Surg 1993; 28: 217-222.
21. de Sá BC, Rezze GG, Scramim AP, et al. Cutaneous melanoma in childhood and adolescence: retrospective study of 32 patients. Melanoma Res 2004; 14: 487-492.
22. Schmid-Wendtner MH, Berking C, Baumert J, et al. Cutaneous melanoma in childhood and adolescence: an analysis of 36 patients. J Am Acad Dermatol 2002; 46: 874-879.
23. Crotty KA, McCarthy SW, Palmer AA, et al. Malignant melanoma in childhood: a clinicopathologic study of 13 cases and comparison with Spitz nevi. World J Surg 1992; 16: 179-185.
24. Ferrari A, Bono A, Baldi M, et al. Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution. Pediatrics 2005; 115: 649-654.
25. Valcayo-Peñalba A, Sánchez-Yus E,. El melanoma maligno en menores de quince años (MM sub-15) Un problema poco y mal estudiado. Actas Dermosifiliogr 1986; 77: 717-723.
26. Lewis KG,. Trends in pediatric melanoma mortality in the United States, 1968 through 2004. Dermatol Surg 2008; 34: 152-159.
27. Mones JM, Ackerman AB,. Melanomas in prepubescent children: review comprehensively, critique historically, criteria diagnostically, and course biologically. Am J Dermatopathol 2003; 25: 223-238.
28. Whiteman DC, Valery P, McWhirter W, Green AC,. Risk factors for childhood melanoma in Queensland, Australia. Int J Cancer 1997; 70: 26-31.
29. Youl P, Aitken J, Hayward N, et al. Melanoma in adolescents: a case-control study of risk factors in Queensland, Australia. Int J Cancer 2002; 98: 92-98.
30. Paradela S, Fernández-Torres R, Fonseca E,. Controversias en el nevus congénito. Actas Dermosifiliogr 2009; 100: 548-561.
31. Aldrink JH, Selim MA, Diesen DL, et al. Pediatric melanoma: a single-institution experience of 150 patients. J Pediatr Surg 2009; 44: 1514-1521.
32. Spatz A, Ruiter D, Hardmeier T, et al. Melanoma in childhood: an EORTC-MCG multicenter study on the clinico-pathological aspects. Int J Cancer 1996; 68: 317-324.
33. Barnhill, RL., Pathology of Melanocytic Nevi and Malignant Melanoma. 2nd edn. Springer, New York, 2004.
34. Al Dhaybi R, Sartelet H, Powell J, Kokta V,. Expression of CD133 + cancer stem cells in childhood malignant melanoma and its correlation with metastasis. Mod Pathol 2010; 23: 376-380.
35. Lohmann CM, Coit DG, Brady MS, et al. Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumors. Am J Surg Pathol 2002; 26: 47-55.
36. Murali R, Sharma RN, Thompson JF, et al. Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors). Ann Surg Oncol 2008; 15: 302-309.
37. Urso C, Borgognoni L, Saieva C, et al. Sentinel lymph node biopsy in patients with "atypical Spitz tumors." A report on 12 cases. Hum Pathol 2006; 37: 816-823.
38. Gamblin TC, Edington H, Kirkwood JM, Rao UN,. Sentinel lymph node biopsy for atypical melanocytic lesions with spitzoid features. Ann Surg Oncol 2006; 13: 1664-1670.
39. Luo S, Sepehr A, Tsao H,. Spitz nevi and other spitzoid lesions part II. Natural history and management. J Am Acad Dermatol 2011; 65: 1087-1092.
40. Luo S, Sepehr A, Tsao H,. Spitz nevi and other spitzoid lesions part I. Background and diagnoses. J Am Acad Dermatol 2011; 65: 1073-1084.